Denali Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Denali Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Denali Therapeutics Inc
Rating: 0.97275
Author: Trendlyne DVM scores

about

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant ...

14.18 0.57 (4.19%)

57.46% Fall from 52W High

305.8K

XNAS Volume

XNAS 30 Jul, 2025 10:40 AM (EDT)

Board Meeting

The next board meeting for Denali Therapeutics Inc is on 01 Aug 2025 for the purpose of Denali Therapeutics Inc Second Quarter Earnings Results for 2025 See details